Cutler Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Cutler Group’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-29,000	Closed	-$25K	–	8022
2016 Q1	$25K	Sell	29,000 -12,400	-30%	-$915K	﹤0.01%	3078
2015 Q4	$163K	Buy	+41,400	New	+$4.56M	0.01%	1349

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Cutler Group's ANAC Position: Q2 2016 in Review

Cutler Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 15,915 shares — an estimated $850K sold.

Cutler Group first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $850K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Cutler Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Cutler Group sold 15,915 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $850K.
Cutler Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
Cutler Group's ANACOR PHARMACEUTICALS INC COM position peaked at $850K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Cutler Group's 13F filing for Q2 2016, filed 12 Jul 2016.